Ubs Group Ag Dbv Technologies S.A. Transaction History

Ubs Group Ag

  • $397 Billion
  • Q1 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$1.77 - $2.76 $3,609 - $5,627
-2,039 Reduced 29.0%
4,992 $9,000
Q2 2022

Aug 10, 2022
SELL
$1.15 - $3.25 $1,064 - $3,009
-926 Reduced 11.64%
7,031 $18,000
Q1 2022

May 16, 2022
BUY
$1.22 - $1.77 $9,707 - $14,083
7,957 New
7,957 $13,000
Q4 2021

Feb 14, 2022
SELL
$1.39 - $5.58 $6,416 - $25,757
-4,616 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$4.71 - $5.92 $15,962 - $20,062
3,389 Added 276.2%
4,616 $23,000
Q2 2021

Aug 13, 2021
SELL
$5.32 - $6.53 $6,713 - $8,240
-1,262 Reduced 50.7%
1,227 $7,000
Q1 2021

May 12, 2021
BUY
$2.75 - $6.57 $5,956 - $14,230
2,166 Added 670.59%
2,489 $13,000
Q4 2020

Feb 11, 2021
SELL
$1.38 - $3.01 $80,935 - $176,533
-58,649 Reduced 99.45%
323 $1,000
Q3 2020

Nov 12, 2020
BUY
$1.58 - $4.77 $4,708 - $14,214
2,980 Added 5.32%
58,972 $102,000
Q2 2020

Jul 31, 2020
BUY
$3.74 - $6.28 $92,744 - $155,731
24,798 Added 79.5%
55,992 $246,000
Q1 2020

May 01, 2020
BUY
$2.33 - $12.98 $30,835 - $171,777
13,234 Added 73.69%
31,194 $122,000
Q4 2019

Feb 14, 2020
SELL
$6.75 - $11.15 $80,979 - $133,766
-11,997 Reduced 40.05%
17,960 $192,000
Q3 2019

Nov 14, 2019
BUY
$8.57 - $10.72 $49,963 - $62,497
5,830 Added 24.16%
29,957 $257,000
Q2 2019

Aug 14, 2019
SELL
$7.58 - $10.0 $32,692 - $43,130
-4,313 Reduced 15.17%
24,127 $198,000
Q1 2019

May 14, 2019
BUY
$5.81 - $9.37 $7,216 - $11,637
1,242 Added 4.57%
28,440 $219,000
Q4 2018

Feb 14, 2019
BUY
$5.75 - $21.85 $104,926 - $398,718
18,248 Added 203.89%
27,198 $174,000
Q3 2018

Nov 14, 2018
SELL
$16.81 - $24.58 $68,013 - $99,450
-4,046 Reduced 31.13%
8,950 $201,000
Q2 2018

Aug 14, 2018
BUY
$18.6 - $24.94 $197,346 - $264,613
10,610 Added 444.68%
12,996 $251,000
Q1 2018

May 15, 2018
SELL
$20.86 - $26.6 $28,035 - $35,750
-1,344 Reduced 36.03%
2,386 $55,000
Q4 2017

Feb 14, 2018
BUY
$20.9 - $49.36 $9,572 - $22,606
458 Added 14.0%
3,730 $92,000
Q3 2017

Nov 14, 2017
BUY
$39.62 - $46.17 $115,096 - $134,123
2,905 Added 791.55%
3,272 $139,000
Q2 2017

Aug 14, 2017
BUY
N/A
279 Added 317.05%
367 $13,000
Q1 2017

Nov 14, 2017
BUY
N/A
88
88 $3,000

Others Institutions Holding DBVT

# of Institutions
32
Shares Held
37.7M
Call Options Held
0
Put Options Held
0
View Full List

About DBV Technologies S.A.

DBVT Quotes by TradingView
  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $175M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email